VisionCare develops and markets proprietary implantable devices and technologies designed to significantly improve vision and quality of life for individuals with untreatable retinal disorders. The company is sponsoring clinical trials of the Implantable Miniature Telescope in the U.S., Europe and other markets. The IMT™ is a prosthetic device designed to improve sight in patients who have bilateral moderate to severe central vision loss due to age-related macular degeneration and other macular disorders. The IMT works with the cornea to project magnified images over a wide field of the retina and improve the ability to recognize images that were either difficult or impossible to see.
Website: www.visioncareinc.net
Investors 1
Funding Rounds 1
| Date | Series | Amount | Investors | Deal News |
| 10.01.2011 | Series E | $31M | - | finsmes.co... |
Mentions in press and media 2